> About EZSCAN

EZSCAN is a revolutionary device for screening and assessment of cardiometabolic risk.

Immediate results

EZSCAN is non invasive and provides immediate results, without any need for patient preparation, fasting or blood drawing. Findings are available following a simple 2 minute test. EZSCAN is therefore perfectly suited for general practitioners, pharmacists, cardiologists and neuroplogists.

Reliable screening test

ROC curves for EZSCAN – Area under curve = 0.88

Recent clinical studies have shown EZSCAN to be highly accurate and re-
producible in head to head comparisons with conventional blood tests.
ESC values measured by EZSCAN had a sensitivity of 75% and a specificity of 100% with an area under the ROC curve of 0.88 . Coefficients of variation on hand and foot measurements were 7% and 5% respectively.
Its good sensitivity, specificity and reproducibility make EZSCAN a reliable tool to assess sudomotor dysfunction, a clinical manifestation of autonomic neuropathy in patients with cardiometabolic risk. [1] [2]

EZSCAN and cardiorespiratory fitness level

A recent study showed that sudomotor dysfunction as assessed by EZSCAN is correlated to cardio-respiratory fitness levels measured by VO2max. The correlation between sudomotor function score and VO2max was r=0.57, p<0.0001 (women) (figure 6) and 0.48, p<0.0001 (men). EZSCAN can be used to assess CVD or metabolic disease risk early and for follow-up of an individual’s preventive interventions [3].